Mechanism of lipid-lowering action of the dipeptidyl peptidase-4 inhibitor, anagliptin, in low-density lipoprotein receptor-deficient mice.
about
Long-Term Effect of Alogliptin on Glycemic Control in Japanese Patients With Type 2 Diabetes: A 3.5-Year Observational Study.The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3).Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients.Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial.Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus.Efficacy of anagliptin as compared to linagliptin on metabolic parameters over 2 years of drug consumption: A retrospective cohort study
P2860
Mechanism of lipid-lowering action of the dipeptidyl peptidase-4 inhibitor, anagliptin, in low-density lipoprotein receptor-deficient mice.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mechanism of lipid-lowering ac ...... otein receptor-deficient mice.
@en
type
label
Mechanism of lipid-lowering ac ...... otein receptor-deficient mice.
@en
prefLabel
Mechanism of lipid-lowering ac ...... otein receptor-deficient mice.
@en
P2093
P2860
P356
P1476
Mechanism of lipid-lowering ac ...... otein receptor-deficient mice.
@en
P2093
Keisuke Inoue
Kohei Kaku
Misako Yasumura
Moritaka Goto
Noriyuki Inoue
Shiori Ito
Sohei Tanabe
Sumihiko Hagita
Takahiro Itou
Takashi Nakagawa
P2860
P304
P356
10.1111/JDI.12593
P577
2016-11-10T00:00:00Z